STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma

Hematol Oncol. 2020 Feb;38(1):106-110. doi: 10.1002/hon.2679. Epub 2019 Nov 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Central Nervous System Neoplasms / drug therapy
  • Central Nervous System Neoplasms / metabolism
  • Central Nervous System Neoplasms / mortality*
  • Central Nervous System Neoplasms / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-10 / cerebrospinal fluid*
  • Interleukin-4 / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Prognosis
  • STAT6 Transcription Factor / metabolism*
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • IL10 protein, human
  • IL4 protein, human
  • STAT6 Transcription Factor
  • STAT6 protein, human
  • Interleukin-10
  • Interleukin-4